Miclodin

Clotrimazole, the active ingredient in Miclodin, is an imidazole antifungal presented as a vaginal formulation for vaginal use. It treats vaginal candidiasis and other vaginal fungal infections in adult women. GNH USA supplies Miclodin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Miclodin (clotrimazole) belongs to the imidazole antifungal class and is used to treat fungal infections of the vagina. - Vaginal candidiasis: eradicates Candida species and relieves itching, burning and discharge. - Other vaginal fungal infections: treats non‑candidal yeast infections causing irritation. - Recurrent vaginal yeast infection: helps prevent recurrence when used as directed.

Miclodin may cause local adverse reactions, most of which are mild and self‑limiting.

Common Side Effects: - Vaginal irritation or burning - Itching or mild rash at the application site - Unpleasant vaginal discharge - Local allergic reaction (redness, swelling) - Unpleasant odor - Mild discomfort during intercourse

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis) - Stevens‑Johnson syndrome or toxic epidermal necrolysis - Persistent or worsening vaginal ulceration - Systemic absorption leading to liver enzyme abnormalities - Severe swelling of the vulva or labia - Unexplained fever or chills

Before using Miclodin, consider the following safety measures. - Pregnancy: consult a healthcare provider before use. - Breastfeeding: discuss potential risks with a physician. - Allergy: avoid if you have known hypersensitivity to clotrimazole or other imidazoles. - Concurrent vaginal products: do not use other intravaginal medications at the same time. - Medical conditions: use with caution in patients with hepatic impairment. - Store at room temperature: keep in the original packaging, protect from moisture and heat.

Miclodin may interact with other medicines; review the following categories.

Major Interactions (Avoid): - Systemic azole antifungals: may increase systemic exposure and toxicity. - Topical corticosteroids: may reduce antifungal efficacy.

Moderate Interactions (Monitor Closely): - Antifungal resistance: prolonged use may select resistant strains. - Hormonal contraceptives: no direct interaction, but monitor efficacy. - Alcohol: no known pharmacokinetic interaction, but advise general caution.